Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.

Hennigan RF, Fletcher JS, Guard S, Ratner N.

Sci Signal. 2019 Apr 23;12(578). pii: eaau8749. doi: 10.1126/scisignal.aau8749.

PMID:
31015291
2.

Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1.

Coover RA, Healy TE, Guo L, Chaney KE, Hennigan RF, Thomson CS, Aschbacher-Smith LE, Jankowski MP, Ratner N.

Acta Neuropathol Commun. 2018 Nov 23;6(1):127. doi: 10.1186/s40478-018-0635-9.

3.

DEK over-expression promotes mitotic defects and micronucleus formation.

Matrka MC, Hennigan RF, Kappes F, DeLay ML, Lambert PF, Aronow BJ, Wells SI.

Cell Cycle. 2015;14(24):3939-53. doi: 10.1080/15384101.2015.1044177. Epub 2015 May 6.

4.

The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway.

Hennigan RF, Moon CA, Parysek LM, Monk KR, Morfini G, Berth S, Brady S, Ratner N.

Oncogene. 2013 Feb 28;32(9):1135-43. doi: 10.1038/onc.2012.135. Epub 2012 Apr 23.

5.

FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.

Mani T, Hennigan RF, Foster LA, Conrady DG, Herr AB, Ip W.

Mol Cell Biol. 2011 May;31(10):1983-96. doi: 10.1128/MCB.00609-10. Epub 2011 Mar 14.

6.

NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation.

Bosco EE, Nakai Y, Hennigan RF, Ratner N, Zheng Y.

Oncogene. 2010 Apr 29;29(17):2540-9. doi: 10.1038/onc.2010.20. Epub 2010 Feb 15.

7.

Fluorescence resonance energy transfer analysis of merlin conformational changes.

Hennigan RF, Foster LA, Chaiken MF, Mani T, Gomes MM, Herr AB, Ip W.

Mol Cell Biol. 2010 Jan;30(1):54-67. doi: 10.1128/MCB.00248-09.

8.

A FRET-based approach for studying conformational changes of a cytoskeleton-related tumor suppressor molecule.

Hennigan RF, Chaiken MF, Foster LA, Ip W.

Methods Mol Biol. 2009;586:143-56. doi: 10.1007/978-1-60761-376-3_7.

PMID:
19768428
9.

Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.

Lepont P, Stickney JT, Foster LA, Meng JJ, Hennigan RF, Ip W.

Mutat Res. 2008 Jan 1;637(1-2):142-51. Epub 2007 Aug 6.

10.

Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration.

Yoon SS, Karabulut AC, Lipscomb JD, Hennigan RF, Lymar SV, Groce SL, Herr AB, Howell ML, Kiley PJ, Schurr MJ, Gaston B, Choi KH, Schweizer HP, Hassett DJ.

EMBO J. 2007 Aug 8;26(15):3662-72. Epub 2007 Jul 12.

11.

Transcription factors control invasion: AP-1 the first among equals.

Ozanne BW, Spence HJ, McGarry LC, Hennigan RF.

Oncogene. 2007 Jan 4;26(1):1-10. Epub 2006 Jun 26. Review.

PMID:
16799638
12.

Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.

Bahassi el M, Myer DL, McKenney RJ, Hennigan RF, Stambrook PJ.

Mutat Res. 2006 Apr 11;596(1-2):166-76. Epub 2006 Feb 14.

PMID:
16481012
13.

Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.

Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, Karabulut AC, Hennigan RF, Hwang SH, Buettner G, Schurr MJ, Mortensen JE, Burns JL, Speert D, Boucher RC, Hassett DJ.

J Clin Invest. 2006 Feb;116(2):436-46. Epub 2006 Jan 26.

14.

Invasion is a genetic program regulated by transcription factors.

Ozanne BW, Spence HJ, McGarry LC, Hennigan RF.

Curr Opin Genet Dev. 2006 Feb;16(1):65-70. Epub 2005 Dec 27. Review.

PMID:
16377173
15.

G protein-induced trafficking of voltage-dependent calcium channels.

Tombler E, Cabanilla NJ, Carman P, Permaul N, Hall JJ, Richman RW, Lee J, Rodriguez J, Felsenfeld DP, Hennigan RF, Diversé-Pierluissi MA.

J Biol Chem. 2006 Jan 20;281(3):1827-39. Epub 2005 Nov 17. Retraction in: J Biol Chem. 2011 Jun 17;286(24):21952.

16.

A 5'-distal enhanceosome in the PDGF-A gene is activated in choriocarcinoma cells via ligand-independent binding of vitamin D receptor and constitutive jun kinase signaling.

Pedigo NG, Zhang H, Bruno ME, Kaetzel CS, Dugan AR, Shanehsaz P, Hennigan RF, Xing Z, Koszewski NJ, Kaetzel DM.

Oncogene. 2005 Apr 14;24(16):2654-66.

PMID:
15829977
17.

Critical regulation of genes for tumor cell migration by AP-1.

Bahassi el M, Karyala S, Tomlinson CR, Sartor MA, Medvedovic M, Hennigan RF.

Clin Exp Metastasis. 2004;21(4):293-304.

PMID:
15554385
18.

Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation.

Bahassi el M, Hennigan RF, Myer DL, Stambrook PJ.

Oncogene. 2004 Apr 8;23(15):2658-63.

PMID:
14968113
19.

RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult.

Bosco EE, Mayhew CN, Hennigan RF, Sage J, Jacks T, Knudsen ES.

Nucleic Acids Res. 2004 Jan 2;32(1):25-34. Print 2004.

20.

Bacterial biofilms of importance to medicine and bioterrorism: proteomic techniques to identify novel vaccine components and drug targets.

Hassett DJ, Limbach PA, Hennigan RF, Klose KE, Hancock RE, Platt MD, Hunt DF.

Expert Opin Biol Ther. 2003 Dec;3(8):1201-7. Review.

PMID:
14640945
21.

Retinoblastoma tumor suppressor: analyses of dynamic behavior in living cells reveal multiple modes of regulation.

Angus SP, Solomon DA, Kuschel L, Hennigan RF, Knudsen ES.

Mol Cell Biol. 2003 Nov;23(22):8172-88.

22.

Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ.

Dev Cell. 2002 Oct;3(4):593-603.

23.

Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways.

Bahassi el M, Conn CW, Myer DL, Hennigan RF, McGowan CH, Sanchez Y, Stambrook PJ.

Oncogene. 2002 Sep 26;21(43):6633-40.

24.

Mechanisms of human neutrophil oxidant production after severe injury.

Quaid G, Cave C, Williams MA, Hennigan RF, Bokoch G, Solomkin JS.

Surgery. 2001 Oct;130(4):669-75; discussion 675-6.

PMID:
11602898
25.
26.

Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.

Conn CW, Hennigan RF, Dai W, Sanchez Y, Stambrook PJ.

Cancer Res. 2000 Dec 15;60(24):6826-31.

27.

Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro.

Sherman L, Sleeman JP, Hennigan RF, Herrlich P, Ratner N.

Oncogene. 1999 Nov 18;18(48):6692-9.

28.

The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.

Malliri A, Symons M, Hennigan RF, Hurlstone AF, Lamb RF, Wheeler T, Ozanne BW.

J Cell Biol. 1998 Nov 16;143(4):1087-99.

29.

AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44.

Lamb RF, Hennigan RF, Turnbull K, Katsanakis KD, MacKenzie ED, Birnie GD, Ozanne BW.

Mol Cell Biol. 1997 Feb;17(2):963-76.

30.

Fos-transformation activates genes associated with invasion.

Hennigan RF, Hawker KL, Ozanne BW.

Oncogene. 1994 Dec;9(12):3591-600.

PMID:
7970719
31.

Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.

Hawker KL, Pintzas A, Hennigan RF, Gillespie DA, Ozanne BW.

J Virol. 1993 Sep;67(9):5487-95.

Supplemental Content

Loading ...
Support Center